Activity value 90taiwan Buyer&Supplier,Last transaction date:
2026-03-15Address: 11f, no.200, sec.1, fu hsing s. rd., daan dist., taipei 106, taiwan, r.o.c.
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for lotus pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 47 transactions, with a transaction quantity of 895 and a transaction weight of 596.8.
tpe-taipei-taiwan taoyuan international airport162.59%>
taipei81.3%>
manila71.13%>
kao hsiung30.49%>
panama city20.32%>
+View All
lotus pharmaceutical co.ltd. is taiwan Buyer&Supplier,
and primarily engages in the import and export business of products such as capsule,nintedanib,soft gelatin capsule.
According to the 52wmb.com global trade database, as of 2026-03-15, the company has completed 3081 international trades,
with its main trading regions covering india,ecuador,philippines etc.
The core products include HS30049099,HS30049099000,HS3004902400 etc,
often transported via tpe-taipei-taiwan taoyuan international airport,port taipei, port manila etc,
and its main trading partners are indtech instruments pvt ltd.,meishi pharma services private limited,alembic pharmaceuticals ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on lotus pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.